世界の非経口薬市場レポート2020年

QYResearchが発行した調査報告書(QYR20ST09119)
◆英語タイトル:Global Parenteral Drugs Sales Market Report 2020
◆商品コード:QYR20ST09119
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年9月(※2024年版があります。お問い合わせください。)
◆ページ数:142
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、北米、ヨーロッパ、日本、アジアなど
◆産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界の非経口薬市場について種類別(LVP医薬品、SVP医薬品)、用途別(Hospitals、 Medical Centers、 Others)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・非経口薬市場の概要
・世界の主要地域別非経口薬市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の非経口薬市場規模2015-2026:種類別(LVP医薬品、SVP医薬品)
・世界の非経口薬市場規模2015-2026:用途別(Hospitals、 Medical Centers、 Others)
・非経口薬の北米市場規模2015-2020
・非経口薬のヨーロッパ市場規模2015-2020
・非経口薬の中国市場規模2015-2020
・非経口薬の日本市場規模2015-2020
・非経口薬の東南アジア市場規模2015-2020
・非経口薬のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・非経口薬の製造コスト分析
・販売チャネル、流通業者、顧客
・非経口薬の市場動向・機会・課題
・調査の結論
【レポートの概要】

A recently published report by QY Research titled Global Parenteral Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Parenteral Drugs market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Parenteral Drug (LVP, SVP) is defined as one intended for injection through the skin or other external boundary tissue, rather than through the alimentary canal, so that active substances they contain are administered, using gravity or force, directly into a blood vessel, organ, tissue, or lesion. They are infused when administered intravenously (IV), or injected when administered intramuscularly (IM), or subcutaneously into the human body. A large volume parenteral (LVP) is a unit dose container of greater than 100ml that is terminally sterilized by heat. Small volume parenteral (SVP) is a “catch-all” for all non-LVP parenterals products except biologicals.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Parenteral Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Parenteral Drugs industry.
Based on our recent survey, we have several different scenarios about the Parenteral Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Parenteral Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Parenteral Drugs market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Parenteral Drugs market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Parenteral Drugs market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Parenteral Drugs market. The report also includes nautical information, where it shows Parenteral Drugs market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Parenteral Drugs market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Parenteral Drugs market.
Parenteral drugs, whether a small-molecule or biologic-based drug substance, has increased their share of the overall drug market although solid-dosage products still prevail.
Geographical Analysis:
Based on region, the global Parenteral Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Parenteral Drugs market are
Ostuka Pharmaceutical
Teva Pharmaceutical Industries
Kelun Pharma
Cook Pharmica
Patheon
BAG Healthcare
Beximco Pharma
Baxter Healthcare Corporation
B. Braun
Fresenius
Albert David
BML Parenteral Drugs
Pfizer (Hospira)
Pisa
Ozon Pharmaceuticals Ltd
Aspen Holdings
PSI Ltd
Wintac Limited
AXA Parenterals Ltd
Acebright
Southwest Pharmaceutical
Abbott
Segment by Type
LVP Drug
SVP Drug
Segment by Application
Hospitals
Medical Centers
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Parenteral Drugs market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Parenteral Drugs market.
• The market share of the global Parenteral Drugs market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Parenteral Drugs market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Parenteral Drugs market.

【レポートの目次】

1 Parenteral Drugs Market Overview
1.1 Parenteral Drugs Product Scope
1.2 Parenteral Drugs Segment by Type
1.2.1 Global Parenteral Drugs Sales by Type (2020-2026)
1.2.2 LVP Drug
1.2.3 SVP Drug
1.3 Parenteral Drugs Segment by Application
1.3.1 Global Parenteral Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Medical Centers
1.3.4 Others
1.4 Parenteral Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Parenteral Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Parenteral Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Parenteral Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Parenteral Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Parenteral Drugs Industry
1.5.1.1 Parenteral Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Parenteral Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Parenteral Drugs Players to Combat Covid-19 Impact

2 Parenteral Drugs Estimate and Forecast by Region
2.1 Global Parenteral Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Parenteral Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Parenteral Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Parenteral Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Parenteral Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Parenteral Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Parenteral Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Parenteral Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Parenteral Drugs Estimates and Projections (2015-2026)
2.4.3 China Parenteral Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Parenteral Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Parenteral Drugs Estimates and Projections (2015-2026)
2.4.6 India Parenteral Drugs Estimates and Projections (2015-2026)
3 Global Parenteral Drugs Competition Landscape by Players
3.1 Global Top Parenteral Drugs Players by Sales (2015-2020)
3.2 Global Top Parenteral Drugs Players by Revenue (2015-2020)
3.3 Global Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parenteral Drugs as of 2019)
3.4 Global Parenteral Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Parenteral Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Parenteral Drugs Players (Opinion Leaders)
4 Global Parenteral Drugs Market Size by Type
4.1 Global Parenteral Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Parenteral Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Parenteral Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Parenteral Drugs Price by Type (2014-2020)
4.2 Global Parenteral Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Parenteral Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Parenteral Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Parenteral Drugs Price Forecast by Type (2021-2026)
5 Global Parenteral Drugs Market Size by Application
5.1 Global Parenteral Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Parenteral Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Parenteral Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Parenteral Drugs Price by Application (2015-2020)
5.2 Global Parenteral Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Parenteral Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Parenteral Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Parenteral Drugs Price Forecast by Application (2021-2026)

3 North America Parenteral Drugs Market Facts & Figures
3.2 North America Parenteral Drugs Sales Market Share by Company (2015-2020)
3.3 North America Parenteral Drugs Sales Market Share by Type (2015-2020)
3.4 North America Parenteral Drugs Sales Market Share by Application (2015-2020)

4 Europe Parenteral Drugs Market Facts & Figures
4.2 Europe Parenteral Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Parenteral Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Parenteral Drugs Sales Market Share by Application (2015-2020)

5 China Parenteral Drugs Market Facts & Figures
5.2 China Parenteral Drugs Sales Market Share by Company (2015-2020)
5.3 China Parenteral Drugs Sales Market Share by Type (2015-2020)
5.4 China Parenteral Drugs Sales Market Share by Application (2015-2020)

6 Japan Parenteral Drugs Market Facts & Figures
6.2 Japan Parenteral Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Parenteral Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Parenteral Drugs Sales Market Share by Application (2015-2020)

7 Southeast Asia Parenteral Drugs Market Facts & Figures
7.2 Southeast Asia Parenteral Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Parenteral Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Parenteral Drugs Sales Market Share by Application (2015-2020)

8 India Parenteral Drugs Market Facts & Figures
8.2 India Parenteral Drugs Sales Market Share by Company (2015-2020)
8.3 India Parenteral Drugs Sales Market Share by Type (2015-2020)
8.4 India Parenteral Drugs Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Parenteral Drugs Business
12.1 Ostuka Pharmaceutical
12.1.1 Ostuka Pharmaceutical Parenteral Drugs Corporation Information
12.1.2 Ostuka Pharmaceutical Parenteral Drugs Business Overview and Total Revenue
12.1.3 Ostuka Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Ostuka Pharmaceutical Parenteral Drugs Products Offered
12.1.5 Ostuka Pharmaceutical Recent Development
12.2 Teva Pharmaceutical Industries
12.2.1 Teva Pharmaceutical Industries Parenteral Drugs Corporation Information
12.2.2 Teva Pharmaceutical Industries Parenteral Drugs Business Overview and Total Revenue
12.2.3 Teva Pharmaceutical Industries Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Teva Pharmaceutical Industries Parenteral Drugs Products Offered
12.2.5 Teva Pharmaceutical Industries Recent Development
12.3 Kelun Pharma
12.3.1 Kelun Pharma Parenteral Drugs Corporation Information
12.3.2 Kelun Pharma Parenteral Drugs Business Overview and Total Revenue
12.3.3 Kelun Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Kelun Pharma Parenteral Drugs Products Offered
12.3.5 Kelun Pharma Recent Development
12.4 Cook Pharmica
12.4.1 Cook Pharmica Parenteral Drugs Corporation Information
12.4.2 Cook Pharmica Parenteral Drugs Business Overview and Total Revenue
12.4.3 Cook Pharmica Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Cook Pharmica Parenteral Drugs Products Offered
12.4.5 Cook Pharmica Recent Development
12.5 Patheon
12.5.1 Patheon Parenteral Drugs Corporation Information
12.5.2 Patheon Parenteral Drugs Business Overview and Total Revenue
12.5.3 Patheon Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Patheon Parenteral Drugs Products Offered
12.5.5 Patheon Recent Development
12.6 BAG Healthcare
12.6.1 BAG Healthcare Parenteral Drugs Corporation Information
12.6.2 BAG Healthcare Parenteral Drugs Business Overview and Total Revenue
12.6.3 BAG Healthcare Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 BAG Healthcare Parenteral Drugs Products Offered
12.6.5 BAG Healthcare Recent Development
12.7 Beximco Pharma
12.7.1 Beximco Pharma Parenteral Drugs Corporation Information
12.7.2 Beximco Pharma Parenteral Drugs Business Overview and Total Revenue
12.7.3 Beximco Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Beximco Pharma Parenteral Drugs Products Offered
12.7.5 Beximco Pharma Recent Development
12.8 Baxter Healthcare Corporation
12.8.1 Baxter Healthcare Corporation Parenteral Drugs Corporation Information
12.8.2 Baxter Healthcare Corporation Parenteral Drugs Business Overview and Total Revenue
12.8.3 Baxter Healthcare Corporation Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Baxter Healthcare Corporation Parenteral Drugs Products Offered
12.8.5 Baxter Healthcare Corporation Recent Development
12.9 B. Braun
12.9.1 B. Braun Parenteral Drugs Corporation Information
12.9.2 B. Braun Parenteral Drugs Business Overview and Total Revenue
12.9.3 B. Braun Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 B. Braun Parenteral Drugs Products Offered
12.9.5 B. Braun Recent Development
12.10 Fresenius
12.10.1 Fresenius Parenteral Drugs Corporation Information
12.10.2 Fresenius Parenteral Drugs Business Overview and Total Revenue
12.10.3 Fresenius Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Fresenius Parenteral Drugs Products Offered
12.10.5 Fresenius Recent Development
12.11 Albert David
12.11.1 Albert David Parenteral Drugs Corporation Information
12.11.2 Albert David Parenteral Drugs Business Overview and Total Revenue
12.11.3 Albert David Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Albert David Parenteral Drugs Products Offered
12.11.5 Albert David Recent Development
12.12 BML Parenteral Drugs
12.12.1 BML Parenteral Drugs Parenteral Drugs Corporation Information
12.12.2 BML Parenteral Drugs Parenteral Drugs Business Overview and Total Revenue
12.12.3 BML Parenteral Drugs Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.12.4 BML Parenteral Drugs Parenteral Drugs Products Offered
12.12.5 BML Parenteral Drugs Recent Development
12.13 Pfizer (Hospira)
12.13.1 Pfizer (Hospira) Parenteral Drugs Corporation Information
12.13.2 Pfizer (Hospira) Parenteral Drugs Business Overview and Total Revenue
12.13.3 Pfizer (Hospira) Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Pfizer (Hospira) Parenteral Drugs Products Offered
12.13.5 Pfizer (Hospira) Recent Development
12.14 Pisa
12.14.1 Pisa Parenteral Drugs Corporation Information
12.14.2 Pisa Parenteral Drugs Business Overview and Total Revenue
12.14.3 Pisa Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Pisa Parenteral Drugs Products Offered
12.14.5 Pisa Recent Development
12.15 Ozon Pharmaceuticals Ltd
12.15.1 Ozon Pharmaceuticals Ltd Parenteral Drugs Corporation Information
12.15.2 Ozon Pharmaceuticals Ltd Parenteral Drugs Business Overview and Total Revenue
12.15.3 Ozon Pharmaceuticals Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Ozon Pharmaceuticals Ltd Parenteral Drugs Products Offered
12.15.5 Ozon Pharmaceuticals Ltd Recent Development
12.16 Aspen Holdings
12.16.1 Aspen Holdings Parenteral Drugs Corporation Information
12.16.2 Aspen Holdings Parenteral Drugs Business Overview and Total Revenue
12.16.3 Aspen Holdings Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Aspen Holdings Parenteral Drugs Products Offered
12.16.5 Aspen Holdings Recent Development
12.17 PSI Ltd
12.17.1 PSI Ltd Parenteral Drugs Corporation Information
12.17.2 PSI Ltd Parenteral Drugs Business Overview and Total Revenue
12.17.3 PSI Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.17.4 PSI Ltd Parenteral Drugs Products Offered
12.17.5 PSI Ltd Recent Development
12.18 Wintac Limited
12.18.1 Wintac Limited Parenteral Drugs Corporation Information
12.18.2 Wintac Limited Parenteral Drugs Business Overview and Total Revenue
12.18.3 Wintac Limited Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Wintac Limited Parenteral Drugs Products Offered
12.18.5 Wintac Limited Recent Development
12.19 AXA Parenterals Ltd
12.19.1 AXA Parenterals Ltd Parenteral Drugs Corporation Information
12.19.2 AXA Parenterals Ltd Parenteral Drugs Business Overview and Total Revenue
12.19.3 AXA Parenterals Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.19.4 AXA Parenterals Ltd Parenteral Drugs Products Offered
12.19.5 AXA Parenterals Ltd Recent Development
12.20 Acebright
12.20.1 Acebright Parenteral Drugs Corporation Information
12.20.2 Acebright Parenteral Drugs Business Overview and Total Revenue
12.20.3 Acebright Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Acebright Parenteral Drugs Products Offered
12.20.5 Acebright Recent Development
12.21 Southwest Pharmaceutical
12.21.1 Southwest Pharmaceutical Parenteral Drugs Corporation Information
12.21.2 Southwest Pharmaceutical Parenteral Drugs Business Overview and Total Revenue
12.21.3 Southwest Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Southwest Pharmaceutical Parenteral Drugs Products Offered
12.21.5 Southwest Pharmaceutical Recent Development
12.22 Abbott
12.22.1 Abbott Parenteral Drugs Corporation Information
12.22.2 Abbott Parenteral Drugs Business Overview and Total Revenue
12.22.3 Abbott Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Abbott Parenteral Drugs Products Offered
12.22.5 Abbott Recent Development

13 Parenteral Drugs Manufacturing Cost Analysis
13.1 Parenteral Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Parenteral Drugs
13.4 Parenteral Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Parenteral Drugs Distributors List
14.3 Parenteral Drugs Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の非経口薬市場レポート2020年(Global Parenteral Drugs Sales Market Report 2020)]についてメールでお問い合わせはこちらでお願いします。